| Name | Title | Contact Details |
|---|
Where Smart, Strategic, Targeted Direct Response Fundraising helps Non-Profits raise funds.
CareerLearning: Learn the skills, earn the certifications, and gain the confidence you need today.
pareIT is a company that uses proprietary artificial intelligence and machine learning algorithms to sort legal case files and extract relevant information from medical records.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
ProofPilot supports clinical trials with the industry`s first fully automated digital protocol platform. The platform orchestrates stakeholder tasks and technology, optimizing clinical workflows, improving stakeholder experiences, and maximizing data quality. Eliminating guesswork and protocol deviations creates high-performance experiences for sites and patients. Founded in 2014, ProofPilot was one of the first global digital clinical trial solutions enabling flawless execution of virtual, hybrid, and in-person research offerings with its patient and site Co-Pilot packages.